Suppr超能文献

冻融触发的季铵化壳聚糖增强微纤化纤维素水凝胶用于高效去除胆红素。

Freezing-triggered gelation of quaternized chitosan reinforced with microfibrillated cellulose for highly efficient removal of bilirubin.

机构信息

College of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming 650092, China.

出版信息

J Mater Chem B. 2022 Nov 3;10(42):8650-8663. doi: 10.1039/d2tb01407f.

Abstract

The highly efficient removal of bilirubin from blood by hemoperfusion for liver failure therapy remains a challenge in the clinical field due to the low adsorption capacity and poor hemocompatibility of currently used carbon-based adsorbents. Polysaccharide-based cryogels seem to be promising candidates for hemoperfusion adsorbents owing to their inherited excellent hemocompatibility. However, the weak mechanical strength and relatively low adsorption capacity of polysaccharide-based cryogels limited their application in bilirubin adsorption. In this work, we presented a freezing-triggered strategy to fabricate QCS/MFC cryogels, which were formed by quaternized chitosan (QCS) crosslinked with divinylsulfonyl methane (BVSM) and reinforced with microfibrillated cellulose (MFC). Ice crystal exclusions triggered the chemical crosslinking to generate the cryogels with dense pore walls. The obtained QCS/MFC cryogels were characterized by FTIR, SEM, stress-strain test, and hemocompatibility assay, which exhibited interconnected macroporous structures, excellent shape-recovery and mechanical performance, and outstanding blood compatibility. Due to the quaternary ammonium functionalization of chitosan, the QCS/MFC showed a high adsorption capacity of 250 mg g and a short adsorption equilibrium time of 3 h. More importantly, the QCS/MFC still exhibited high adsorption efficiency (over 49.7%) in the presence of 40 g L albumin. Furthermore, the QCS/MFC could also maintain high dynamic adsorption efficiency in self-made hemoperfusion devices. This facile approach provides a new avenue to develop high-performance hemoperfusion adsorbents for bilirubin removal, showing great promise for the translational therapy of hyperbilirubinemia.

摘要

由于目前使用的基于碳的吸附剂的吸附容量低和血液相容性差,通过血液灌流治疗肝功能衰竭来高效去除胆红素仍然是临床领域的一个挑战。多糖基冷冻凝胶由于其固有的良好血液相容性,似乎是血液灌流吸附剂的有前途的候选物。然而,多糖基冷冻凝胶的机械强度弱和相对低的吸附容量限制了它们在胆红素吸附中的应用。在这项工作中,我们提出了一种冷冻触发策略来制备 QCS/MFC 冷冻凝胶,它由季铵化壳聚糖(QCS)与二乙烯基砜甲烷(BVSM)交联,并与微纤化纤维素(MFC)增强。冰晶体排除触发了化学交联,生成了具有致密孔壁的冷冻凝胶。所得 QCS/MFC 冷冻凝胶通过傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)、应力-应变试验和血液相容性试验进行了表征,结果表明其具有互穿的大孔结构、优异的形状恢复和机械性能以及出色的血液相容性。由于壳聚糖的季铵化功能化,QCS/MFC 表现出 250mg/g 的高吸附容量和 3h 的短吸附平衡时间。更重要的是,在存在 40g/L 白蛋白的情况下,QCS/MFC 仍表现出高吸附效率(超过 49.7%)。此外,QCS/MFC 还可以在自制的血液灌流装置中保持高动态吸附效率。这种简便的方法为开发用于胆红素去除的高性能血液灌流吸附剂提供了新途径,为高胆红素血症的转化治疗展示了巨大的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验